|
The US Healthcare Formula Cost Control and True Innovation November 25, 2011 By | Legislative and secular challenges are forcing a sea change in the US healthcare sector. Whether or not US healthcare reform is implemented as proposed, changes to the US healthcare system over the next three to five years will be sweeping—and the investment implications broad. We identify the stocks that are positioned for long-term gain. The US Healthcare Formula Blue Paper |
